Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer stem cells (CSCs) drive treatment failure and relapse due to drug resistance and self-renewal.
• Targeting CSCs is essential for improving cancer therapy efficacy.
• Nanotechnology offers potential solutions for precise drug delivery to CSCs.

Purpose of the Study:

• To review exosome-based drug delivery systems for targeting cancer stem cells (CSCs).
• To highlight engineering strategies enhancing exosome efficiency and specificity for CSC targeting.
• To discuss the potential of exosomes in overcoming cancer treatment resistance.

Main Methods:

• Review of current research on exosome-based delivery systems.
• Focus on exosomal engineering approaches for CSC targeting.
• Analysis of exosome properties for drug and gene delivery.

Main Results:

• Exosomes are natural, non-toxic, and non-immunogenic nanovesicles.
• Engineered exosomes demonstrate improved delivery capacity and targeting specificity for CSCs.
• Exosome-based systems show promise as nanocarriers for anti-cancer drugs and genes.

Conclusions:

• Exosome-based nanodrug delivery systems are a promising strategy for targeting cancer stem cells (CSCs).
• Exosomal engineering enhances their potential for overcoming drug resistance and improving cancer treatment.
• Further exploration of exosome-based therapies is warranted for clinical application in oncology.